PTCT

Conviction 96HealthcareScan · Fri, Jun 26, 2026

PTCT$84.36-0.18%

ResistanceSupportVol 14Insider sell

Vol MA14 2.74M

Mar 27Apr 15May 4May 20Jun 9Jun 26

PTC THERAPEUTICS, INC.PHARMACEUTICAL PREPARATIONSwww.ptcbio.com ↗

Price84.36

Change-0.18%

Gap+1.50%

Rel volume2.43×

Avg volume2.26M

Avg $ vol174.69M

SMA 2075.89

SMA 5072.22

SMA 20070.94

Price vs 50+16.81%

Price vs 200+18.92%

MA stackbullish

50/200 cross—

Supertrendup · 75.76

RSI (14)71

MACD hist1.06

MACD cross—

Stoch %K / %D85 / 88

ADX (14)25

+DI / −DI31 / 12

RSI divergence—

MACD divergence—

ATR %+3.74%

ADR %3.93%

52w high86.25

52w low43.30

From 52w high-2.19%

Above 52w low+94.83%

New 52w highNo

SqueezeOff

Bollinger width26.79%

%B0.92

Donchian pos86.32%

Donchian high87.03

Donchian low67.51

AVWAP (52w high)74.17

vs AVWAP high+13.74%

AVWAP (52w low)70.69

vs AVWAP low+19.33%

OBV trendUp

Chaikin MF (20)0.12

Today vs 20d2.43×

Avg vol (14d)2.74M

Avg vol (20d)2.26M

Avg $ vol (20d)174.69M

Market cap—

RS 3m (vs SPY)+14.81%

RS 6m (vs SPY)-0.11%

RS line new highYes

Trend template7/8

Technical rank80.1

1 week+6.81%

1 month+19.39%

3 months+25.91%

6 months+8.57%

1 year+72.55%

YTD+9.93%

P/E1.03

P/B-3.88

P/S0.41

P/FCF1.00

EPS7.78

Div yield—

ROE-378.27%

ROA23.79%

Debt/Eq-3.17

Current2.44

EV/EBITDA0.49

Gross margin—

Net margin39.44%

Rev growth114.51%

EPS growth287.90%

Price target97.30

Target upside15.16%

Analyst ratingBuy

Institutional125.99%

Ent. value439.8M

Revenue272.55M

Net income-2.81M

Gross profit—

Free cash flow702.34M

IndustryPHARMACEUTICAL PREPARATIONS

ExchangeNasdaq

Shares out—

Employees991

ListedThu, Jun 20, 2013

Free float—

Float %—

Short interest—

Days to cover—

Short volume—

Squeeze score—

Next earnings—

EPS forecast—

Last EPS vs est—

Last surprise—

Setup gradeA+

Conviction96 / 100

Pattern quality—

Tech rank80.1 / 100

Group rank50 / 100

Status laneNo active setup

Setup direction—

Pattern family

Resistance77.01

Support65.70

Days since event—

Candle confirm—

News sentiment—

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in PTCT

All disclosures →

No recent disclosed trades by Congress in PTCT. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in PTCT · 3 buys · 7 sells

Insider	Side	Shares	Value	Traded	Filed
Almstead Neil Gregory CHIEF TECHNICAL OPS OFFICER · Common Stock · 2026-06-22	Sell	12.13K	$978K	2026-06-22	2026-06-24
Almstead Neil Gregory CHIEF TECHNICAL OPS OFFICER · Common Stock · 2026-06-22	Exercise	23.75K	$610K	2026-06-22	2026-06-24
Almstead Neil Gregory CHIEF TECHNICAL OPS OFFICER · Common Stock · 2026-06-22	Sell	11.62K	$944K	2026-06-22	2026-06-24
Almstead Neil Gregory CHIEF TECHNICAL OPS OFFICER · Stock Option (Right to Buy) · 2026-06-22	Exercise	23.75K	—	2026-06-22	2026-06-24
Utter Christine Marie SVP, CHIEF ACCOUNTING OFFICER · Common Stock · 2026-06-17	Exercise	19.69K	$506K	2026-06-17	2026-06-22
Utter Christine Marie SVP, CHIEF ACCOUNTING OFFICER · Common Stock · 2026-06-17	Sell	19.69K	$1.5M	2026-06-17	2026-06-22
Utter Christine Marie SVP, CHIEF ACCOUNTING OFFICER · Stock Option (Right to Buy) · 2026-06-17	Exercise	19.69K	—	2026-06-17	2026-06-22
Boulding Mark Elliott EXEC. VP AND CLO · Common Stock · 2026-06-17	Exercise	2.01K	$94K	2026-06-17	2026-06-22
Boulding Mark Elliott EXEC. VP AND CLO · Common Stock · 2026-06-17	Sell	1.7K	$134K	2026-06-17	2026-06-22
Boulding Mark Elliott EXEC. VP AND CLO · Common Stock · 2026-06-17	Sell	309	$24K	2026-06-17	2026-06-22

SEC filings

EDGAR filings in PTCT · 10 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.

Start free — 7-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.